TROG and the TSC work closely with our members to ensure that our trials and new proposals address the key priorities in radiation oncology and that we are horizon scanning for emerging technologies and techniques in radiation medicine.

A number of working parties, committees and special interest groups provide guidance to the TSC including:

• TROG Working Parties (WP): Vital in shaping the research priorities of TROG by identifying gaps in research, developing new research concepts, reviewing the scientific merit of research proposals, and providing expert advice. Our tumour stream Working Parties are comprised of members from many craft groups and disciplines, with a focus on Head, Neck & Skin (HNS); Breast; Central Nervous System (CNS); Genitourinary (GU) and Lung cancers.
• Secondary Data Analysis Committee (SDAC): Oversees the development of guidelines and procedures for secondary analysis of TROG data.
• New Technologies and Techniques Committee (NTTC): Ensures that up-to-date guidelines and procedures are available for the implementation of new technologies in TROG clinical trials.
• Independent Data and Safety Monitoring Committee (IDSMC): Monitors progress of all TROG phase III and late phase II clinical trials in relation to quality processes and procedure and ensures the safety of patients and that wherever possible, each trial meets its primary objectives.
• TROG Publications Committee (TPC): Provides peer review in the form of independent scientific review of material and timelines, helping to maintain high standards and encouraging accurate, thorough and credible research reporting.
• TROG Special Interest Groups (SIG): Composed of TROG members who have an interest in clinical trial research involving specific technology or techniques in radiation oncology, current groups include, Particle Therapy SIG, MR in Radiation Therapy SIG and Interventional Oncology SIG.